Eli Lilly Profit Rises as Weight-Loss Drug Demand Surges
Lilly(US:LLY) WSJ·2026-02-04 12:22Group 1 - Eli Lilly reported higher fourth-quarter profit driven by increased demand for its GLP-1 weight-loss drugs [1]
Lilly(US:LLY) WSJ·2026-02-04 12:22Lilly(US:LLY) WSJ·2026-02-04 12:22